You are not logged in.
This means you
CAN ONLY VIEW reports that were published prior to Saturday, September 7, 2024.
You
MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.
AFTER MARKET UPDATE - FRIDAY, MARCH 13TH, 2015
Previous After Market Report Next After Market Report >>>
|
|
|
|
DOW |
-145.91 |
17,749.31 |
-0.82% |
|
Volume |
789,455,080 |
+8% |
|
Volume |
1,723,767,940 |
-0% |
|
NASDAQ |
-21.53 |
4,871.76 |
-0.44% |
|
Advancers |
923 |
29% |
|
Advancers |
1,075 |
36% |
|
S&P 500 |
-12.55 |
2,053.40 |
-0.61% |
|
Decliners |
2,127 |
67% |
|
Decliners |
1,815 |
60% |
|
Russell 2000 |
-4.50 |
1,232.14 |
-0.36% |
|
52 Wk Highs |
75 |
|
|
52 Wk Highs |
99 |
|
|
S&P 600 |
-2.96 |
707.24 |
-0.42% |
|
52 Wk Lows |
123 |
|
|
52 Wk Lows |
62 |
|
|
 |
Breadth Negative as Major Averages Fell
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
For the week, the Dow lost -0.6%, the S&P finished -0.9% lower and the NASDAQ declined -1.1%. Stocks finished Friday lower. The S&P 500 declined 12 points to 2,053. The NASDAQ was off 21 points to 4,871. The volume total on the NYSE was higher than the prior session while volume on the Nasdaq exchange was near the prior session total. Breadth was negative as decliners led advancers by more than a 2-1 margin on the NYSE and by about 9-5 on the Nasdaq exchange. Leadership contracted as there were 42 high-ranked companies from the CANSLIM.net Leaders List that made new 52-week highs and appeared on the CANSLIM.net BreakOuts Page, down from the prior session total of 55 stocks. New 52-week lows outnumbered new 52-week highs on the NYSE yet new highs outnumbered new lows on the Nasdaq exchange. There were gains for 5 of the 12 high-ranked companies currently on the Featured Stocks Page.
Concerning the M criteria, the major averages' uptrend has recently come under pressure. Any sustained rally for the major averages requires a healthy crop of stocks hitting new highs. It would not bode well for the market outlook if new 52-week highs continue to contract and the new 52-week lows list expands. New buying efforts should only be made in stocks meeting all of the fundamental and technical guidelines the fact-based investment system. Meanwhile, stand ready to take swift action if any stocks you own trigger any worrisome technical sell signals.
PICTURED: The Dow Jones Industrial Average fell 145 points to 17,749 on Friday. It saw slighly above average volume behind recent losses as it slumped below its 50-day moving average (DMA) line.
The major averages retreated as the dollar strengthened and oil prices slid lower. In economic data, a measure of producer prices for February unexpectedly fell -0.5% amid oil price declines. For March, a preliminary reading of consumer confidence slumped to a four-month low versus estimates for a slight gain.
At the close, all 10 S&P 500 sectors were lower. Industrials and utilities weighed on the index the most. United Technologies (UTX -2.1%), despite announcing a $2.2 billion share buyback, while General Electric (GE -1.4%) fell. In utilities, Duke Energy (DUK -0.9%) edged lower. Materials also lagged, as Freeport McMoRan (FCX -4%) sank. Herbalife (HLF +8.2%) was a bright spot that gained amid reports that Bill Ackman may have manipulated the stock's price.
Treasuries fluctuated around break-even. The 10-year note declined 1/32 to yield 2.12%.
Commodities were mixed. WTI crude tumbled -4% to $45.14/brl., but COMEX gold advanced +0.2% to $1,154.50/oz. In FOREX, the dollar gained +0.8%. The euro fell -1.4% to $1.0482/EUR and adding to the -3.3% weekly loss. The yen dropped -0.1% to ¥121.40/USD.
The Featured Stocks Page shows recent notes and Headline Links directing members to detailed analysis with data-packed graphs annotated by a Certified expert. See the Premium Member Homepage for archives to all prior pay reports published.
|
Kenneth J. Gruneisen started out as a licensed stockbroker in August 1987, a couple of months prior to the historic stock market crash that took the Dow Jones Industrial Average down -22.6% in a single day. He has published daily fact-based fundamental and technical analysis on high-ranked stocks online for two decades. Through FACTBASEDINVESTING.COM, Kenneth provides educational articles, news, market commentary, and other information regarding proven investment systems that work in good times and bad.
Comments contained in the body of this report are technical opinions only and are not necessarily those of Gruneisen Growth Corp. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. Our firm, employees, and customers may effect transactions, including transactions contrary to any recommendation herein, or have positions in the securities mentioned herein or options with respect thereto. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. |
|
 |
Semiconductor, Biotech, and Broker/Dealer Indexes Rose
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
The Biotechnology Index ($BTK +0.39%) and Semiconductor Index ($SOX +0.71%) both posted small gains while the Networking Index ($NWX -0.70%) lost ground. The Retail Index ($RLX -0.80%) was weaker and created a drag on the major averages. Financial shares were mixed as the Bank Index ($BKX -0.74%) slumped while the Broker/Dealer Index ($XBD +0.22%) posted a small gain. The Oil Services Index ($OSX -2.59%) suffered a big loss while the Integrated Oil Index ($XOI -0.37%) edged lower and the Gold & Silver Index ($XAU +0.02%) finished flat.
Charts courtesy www.stockcharts.com
PICTURED: The Broker/Dealer Index ($XBD +0.22%) is perched at new highs after rebounding from its 200-day moving average (DMA) line.
| Oil Services |
$OSX |
182.10 |
-4.85 |
-2.59% |
-13.64% |
| Integrated Oil |
$XOI |
1,273.58 |
-4.76 |
-0.37% |
-5.53% |
| Semiconductor |
$SOX |
707.79 |
+5.02 |
+0.71% |
+3.05% |
| Networking |
$NWX |
372.63 |
-2.62 |
-0.70% |
+4.11% |
| Broker/Dealer |
$XBD |
189.50 |
+0.42 |
+0.22% |
+2.63% |
| Retail |
$RLX |
1,109.68 |
-8.90 |
-0.80% |
+7.45% |
| Gold & Silver |
$XAU |
65.58 |
+0.01 |
+0.02% |
-4.65% |
| Bank |
$BKX |
73.45 |
-0.55 |
-0.74% |
-1.09% |
| Biotech |
$BTK |
4,072.82 |
+16.01 |
+0.39% |
+18.43% |
|
|
|
 |
Extended From Base After Completing New Public Offering
Kenneth J. Gruneisen - Passed the CAN SLIM® Master's Exam
Actavis plc (ACT +$0.32 or +0.11% to $298.95) is perched at its all-time high, extended from its prior base. It completed a new Public Offering on 2/25/15. Recently it reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system, raising some fundamental concerns.
Like any stock, on pullbacks it is important to watch how it acts near its 50-day moving average (DMA) line ($279.18). It found prompt support near its 50 DMA line earlier. More damaging losses leading to a violation could trigger a technical sell signal. It was last shown in this FSU section on 2/24/15 with annotated graphs under the headline, "Perched At High it Proposed a New Public Offering".
The Medical - Generic Drugs industry group currently has a 99 Group Relative Strength Rating. Leadership from other issues in the group is a reassuring sign concerning the L criteria. The group had an 81 rating when it was shown in this FSU section on 12/29/14 with annotated graphs under the headline, "Formed New Base Above Prior Highs and 50-Day Moving Average". ACT was first highlighted in yellow in the 6/20/14 mid-day report (read here) with a pivot point based on its 2/26/14 high plus 10 cents. Its annual earnings (A criteria) history has also been strong. The number of top-rated funds owning its shares has been on the rise, up from 1,219 in Sep '13 to 1,984 in Dec '14, and its Up/Down Volume ratio of 1.4 is an unbiased indication its shares have been under accumulation over the past 50 days, reassuring signs concerning the I criteria.
|
|
|
Color Codes Explained :
Y - Better candidates highlighted by our
staff of experts.
G - Previously featured
in past reports as yellow but may no longer be buyable under the
guidelines.
***Last / Change / Volume data in this table is the closing quote data***
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
ACT
-
NYSE
Actavis plc
Medical-Generic Drugs
|
$298.95
|
+0.32
0.11% |
$299.50
|
2,660,520
88.54% of 50 DAV
50 DAV is 3,005,000
|
$299.88
-0.31%
|
12/29/2014
|
$260.22
|
PP = $272.85
|
|
MB = $286.49
|
Most Recent Note - 3/13/2015 6:50:00 PM
G - Completed a new Public Offering on 2/25/15. Reported Dec '14 earnings +23%, below the +25% minimum guideline (C criteria) of the fact-based investment system. Its 50 DMA line defines support where violations would raise more serious concerns. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Extended From Base After Completing New Public Offering - 3/13/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AKAM
-
NASDAQ
Akamai Technologies Inc
INTERNET - Internet Software and Services
|
$70.81
|
-0.21
-0.30% |
$71.30
|
1,364,288
80.58% of 50 DAV
50 DAV is 1,693,000
|
$71.83
-1.42%
|
2/13/2015
|
$68.46
|
PP = $65.49
|
|
MB = $68.76
|
Most Recent Note - 3/10/2015 5:38:27 PM
G - Pulled back toward its "max buy" level with today's 3rd consecutive loss. Prior highs in the $65 area define initial support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Holding Ground Extended From Prior Base - 3/4/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
AMBA
-
NASDAQ
Ambarella Inc
ELECTRONICS - Semiconductor - Specialized
|
$68.44
|
+0.92
1.36% |
$68.45
|
1,431,559
70.14% of 50 DAV
50 DAV is 2,041,000
|
$69.25
-1.17%
|
3/2/2015
|
$60.54
|
PP = $63.30
|
|
MB = $66.47
|
Most Recent Note - 3/10/2015 5:36:00 PM
G - Closed just above its "max buy" level today and its color code is changed to green. Disciplined investors avoid chasing stocks more than +5% above their prior highs. Reported earnings +162% on +62% sales revenues for the Jan '15 quarter, continuing to show impressive sales revenues and earnings acceleration in sequential quarterly comparisons. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Rallied Above Max Buy Level Following Strong Earnings News - 3/10/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
EPAM
-
NYSE
Epam Systems Inc
COMPUTER SOFTWARE and SERVICES - Information Technology Service
|
$61.47
|
-0.19
-0.31% |
$62.00
|
265,258
75.14% of 50 DAV
50 DAV is 353,000
|
$63.50
-3.20%
|
2/5/2015
|
$51.39
|
PP = $52.99
|
|
MB = $55.64
|
Most Recent Note - 3/9/2015 4:27:21 PM
G - Perched near its 52-week high, extended from the prior base. Prior highs in the $52 area define support to watch on pullbacks.
>>> FEATURED STOCK ARTICLE : Extended From Base Following Volume Driven Gains - 2/26/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
FB
-
NASDAQ
Facebook Inc Cl A
INTERNET
|
$78.05
|
-0.88
-1.11% |
$79.38
|
18,487,122
73.67% of 50 DAV
50 DAV is 25,096,100
|
$82.17
-5.01%
|
2/20/2015
|
$81.79
|
PP = $78.47
|
|
MB = $82.39
|
Most Recent Note - 3/11/2015 6:21:02 PM
G - Testing support at its 50 DMA line. While consolidating near it 52 week high it has made limited progress, and its Relative Strength rating, at 71 now, is below the 80+ minimum guideline for new buy candidates. See the latest FSU analysis for more details and new annotated graphs.
>>> FEATURED STOCK ARTICLE : Relative Strength Rating Fell While Encountering Resistance - 3/11/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
ILMN
-
NASDAQ
Illumina Inc
DRUGS - Biotechnology
|
$188.21
|
+0.10
0.05% |
$189.58
|
1,023,581
83.16% of 50 DAV
50 DAV is 1,230,900
|
$213.33
-11.78%
|
12/30/2014
|
$186.26
|
PP = $196.00
|
|
MB = $205.80
|
Most Recent Note - 3/12/2015 6:58:45 PM
G - There was a "negative reversal" on 1/28/15 after touching a new 52-week high. Down today on higher but still below average volume, slumping further below its 50 DMA line raising greater concerns. It remains within -11.8% of its high, however its Relative Strength rating has slumped to 70, below the 80+ minimum for buy candidates.
>>> FEATURED STOCK ARTICLE : Found Support at 50-Day Moving Average Line But Relative Strength Has Slumped - 3/5/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
JLL
-
NYSE
Jones Lang Lasalle Inc
REAL ESTATE - Property Management/Developmen
|
$158.75
|
-2.40
-1.49% |
$161.49
|
238,731
78.79% of 50 DAV
50 DAV is 303,000
|
$164.48
-3.48%
|
2/3/2015
|
$156.95
|
PP = $154.66
|
|
MB = $162.39
|
Most Recent Note - 3/12/2015 7:02:41 PM
Y - Gapped up today and finished near the session high with a gain backed by below average volume. Prior highs in the $154 area and its 50 DMA line acted as support. Subsequent losses below the recent low ($153.42 on 3/11/15) would raise greater concerns and trigger a technical sell signal.
>>> FEATURED STOCK ARTICLE : Wedged Above Prior Highs Getting Extended - 2/25/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
LNKD
-
NYSE
Linkedin Corp Class A
INTERNET - Internet Information Providers
|
$259.12
|
-7.30
-2.74% |
$263.88
|
1,698,933
109.33% of 50 DAV
50 DAV is 1,554,000
|
$276.18
-6.18%
|
2/6/2015
|
$269.83
|
PP = $243.35
|
|
MB = $255.52
|
Most Recent Note - 3/13/2015 6:52:18 PM
G - Gapped down today for a loss on higher (near average) volume. Made no progress since the considerable "breakaway gap" noted in the 2/06/15 mid-day report (read here). It remains extended from prior highs.
>>> FEATURED STOCK ARTICLE : Holding Ground Following Breakaway Gap - 2/27/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
NXPI
-
NASDAQ
Nxp Semiconductors N V
ELECTRONICS - Semiconductor - Broad Line
|
$104.67
|
+6.09
6.17% |
$105.12
|
8,271,055
224.63% of 50 DAV
50 DAV is 3,682,000
|
$100.86
3.77%
|
1/5/2015
|
$76.43
|
PP = $78.44
|
|
MB = $82.36
|
Most Recent Note - 3/13/2015 12:38:51 PM
G - Getting more extended from any sound base after gapping up today. Gapped up for a considerable gain and new all-time high on 3/02/15 news it will acquire Freescale Semiconductor Inc (FSL) in an $11.8 Billion deal. Disciplined investors avoid chasing extended stocks.
>>> FEATURED STOCK ARTICLE : Very Extended Following Gap Up Gain on M&A News - 3/9/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
PANW
-
NYSE
Palo Alto Networks
Computer Sftwr-Security
|
$141.34
|
+0.00
0.00% |
$142.97
|
958,453
74.18% of 50 DAV
50 DAV is 1,292,000
|
$149.35
-5.36%
|
7/30/2014
|
$84.21
|
PP = $85.88
|
|
MB = $90.17
|
Most Recent Note - 3/9/2015 12:44:53 PM
G - Pulling back from its 52-week high with above average volume behind today's 4th consecutive loss. Its 50 DMA line (now $130.44) defines near-term support to watch on pullbacks where a violation may trigger a technical sell signal. Reported earnings +90% on +54% sales revenues for the Jan '15 quarter. After breaking out 9/02/14 it has spent very little time basing, and it is very extended from any sound base, yet could produce more climactic gains.
>>> FEATURED STOCK ARTICLE : Fundamentals Improved But No New Base Has Formed - 3/12/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
Symbol/Exchange
Company Name
Industry Group |
PRICE |
CHANGE
(%Change) |
Day High |
Volume
(% DAV)
(% 50 day avg vol) |
52 Wk Hi
% From Hi |
Featured
Date |
Price
Featured |
Pivot Featured |
|
Max Buy |
QLYS
-
NASDAQ
Qualys Inc
Computer Sftwr-Security
|
$43.54
|
-0.45
-1.02% |
$44.75
|
335,322
91.62% of 50 DAV
50 DAV is 366,000
|
$50.00
-12.92%
|
2/6/2015
|
$42.24
|
PP = $40.84
|
|
MB = $42.88
|
Most Recent Note - 3/9/2015 4:19:59 PM
G - Retreated further from its 52-week high with today's 2nd consecutive loss backed by even higher above average volume. Previously noted - "It is extended from the prior base. Prior highs in the $40-41 area and its 50 DMA line define the nearest chart support level."
>>> FEATURED STOCK ARTICLE : Near Highs and Tallying Another Big Volume-Driven Gain - 3/2/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
VRX
-
NYSE
Valeant Pharmaceuticals
DRUGS - Drug Manufacturers - Other
|
$197.43
|
+4.81
2.50% |
$198.61
|
4,783,583
141.07% of 50 DAV
50 DAV is 3,391,000
|
$206.84
-4.55%
|
1/5/2015
|
$144.84
|
PP = $149.90
|
|
MB = $157.40
|
Most Recent Note - 3/11/2015 6:26:49 PM
G - Down today on heavy volume after news Endo International (ENDP) made an unsolicited offer to buy Salix Pharmaceuticals (SLXP). VRX's latest earnings for Dec '14 quarter raised concerns. It is very extended from any sound base. Its 50 DMA line defines the closest support to watch.
>>> FEATURED STOCK ARTICLE : Extended From Sound Base; Earnings Below +25% Raised Concerns - 3/3/2015
View all notes |
Set NEW NOTE alert |
CANSLIM.net Company Profile |
SEC
News |
Chart |
Request a new note
C
A N
S L
I M
|
|
|
|
THESE ARE NOT BUY RECOMMENDATIONS!
Comments contained in the body of this report are technical
opinions only. The material herein has been obtained
from sources believed to be reliable and accurate, however,
its accuracy and completeness cannot be guaranteed.
This site is not an investment advisor, hence it does
not endorse or recommend any securities or other investments.
Any recommendation contained in this report may not
be suitable for all investors and it is not to be deemed
an offer or solicitation on our part with respect to
the purchase or sale of any securities. All trademarks,
service marks and trade names appearing in this report
are the property of their respective owners, and are
likewise used for identification purposes only.
This report is a service available
only to active Paid Premium Members.
You may opt-out of receiving report notifications
at any time. Questions or comments may be submitted
by writing to Premium Membership Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 1-800-965-8307
or 954-785-1121.
|
|
|
